Skip to content

The Addition of Whole Grains to the Diets of Middle-school Children

The Addition of Whole Grains to the Diets of Middle-school Children: A Study of Digestive Health and Immune Defenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01094652
Enrollment
83
Registered
2010-03-29
Start date
2010-02-28
Completion date
2010-04-30
Last updated
2012-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Adolescent, Whole grain, Digestive health, Dietary fiber, Grain, Microbiota, Inflammation, Mucosal Immunity

Brief summary

The Dietary Guidelines for Americans recommend that children and adolescents consume whole-grain products often; at least half the grains should be whole grains. Few, if any studies, examine the benefit of whole grains on the health of adolescents. The purpose of this study is to determine if adolescents eating diets rich in whole grains vs. diets rich in refined grains (i.e., a typical diet) have improved markers of digestive and immune health.

Detailed description

Middle-school students will be recruited and randomized to receive \>/=80 g of whole grains (\>/=5 servings) or similar foods made with refined grains each day for six weeks. Based on treatment group, subjects will be provided either whole grain or refined grain foods and snacks. They will be instructed on how to use these foods to replace other foods already contained in the diet. Stool, blood, and saliva samples will be obtained at baseline and at study end to examine the microbiota and markers of digestive and immune health. Daily records will be maintained by the students to assess bowel habits and compliance. It is anticipated that whole grains will increase stool bulk resulting in increased stool frequency and softer stools. Additionally, fermentation of the fiber within the colon will alter the microbiota profile. Because the majority of the immune system resides within the gastrointestinal tract, improved balance of the intestinal microbiota may prime the immune system thus contributing to improved immune defense.

Interventions

DIETARY_SUPPLEMENTWhole grain diet

Subjects were told to consume three different kinds of study food each day. The goal was an intake of greater than or equal to 80 g of whole grains per day.

DIETARY_SUPPLEMENTRefined grain diet

The refined grain food products were matched as closely as possible to the foods contained in the whole grain diet. Subjects were told to consume three different kinds of study food each day.

Sponsors

General Mills
CollaboratorINDUSTRY
University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
11 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* Middle-school student at Westwood Middle School, Gainesville, FL * Parental/guardian consent * Willing to eat three different study foods each day for six weeks * Willing to provide two blood samples and two saliva samples over the course of the study

Exclusion criteria

* Taking medications for constipation or diarrhea * Antibiotic therapy within the past four weeks prior to randomization * Takes probiotics or consumes greater than three servings of yogurt per week * Has any diseases or illnesses such as gastrointestinal disease (gastric ulcers, Crohn's, ulcerative colitis, etc.), other chronic diseases (diabetes, kidney disease, etc.) or immune-modulating diseases (HIV, AIDS, autoimmune, hepatitis, cancer, etc.) * Has any food allergies (wheat, soy, egg, milk, gluten, nuts, or any other food or food ingredient)

Design outcomes

Primary

MeasureTime frame
Stool frequency6 weeks

Secondary

MeasureTime frameDescription
Changes in overall microbiota diversity6 weeksMicrobial diversity will be measured by DGGE profiling to detect large distortions. Quantitative changes in the proportions of select bacteria will be measured using qPCR.
Inflammatory markers6 weeksSerum CRP, fibrinogen, IL-1, IL-6, and antioxidant capacity; mitogen-induced cytokine production including Th1, Th2, and inflammatory cytokines
Secretory IgA6 weeksSalivary and fecal sIgA

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026